Bellevue Life Sciences Acquisition Corp. (BLAC) Financials

$11.53

south_east
-$0 (0%)
Day's range
$11.29
Day's range
$11.53

BLAC Income statement / Annual

Last year (2023), Bellevue Life Sciences Acquisition Corp.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Bellevue Life Sciences Acquisition Corp.'s net income was $403,780.00. See Bellevue Life Sciences Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $1.83 M $35,388.00 $3,308.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $1.83 M $35,388.00 $3,308.00 $23,812.00
Other Expenses $0.00 $0.00 $0.00 $0.00
Operating Expenses $1.83 M $35,388.00 $3,308.00 $23,812.00
Cost And Expenses $1.83 M $35,388.00 $3,308.00 $23,812.00
Interest Income $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $2.78 M $228,485.00 $236,558.00 $206,297.00
EBITDA $944,591.00 -$35,388.00 -$3,308.00 -$23,810.00
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net $2.78 M $0.00 $0.00 -$2.00
Income Before Tax $944,591.00 -$35,388.00 -$3,308.00 -$23,812.00
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $540,811.00 -$228,483.00 -$236,556.00 -$206,297.00
Net Income $403,780.00 -$35,388.00 -$3,308.00 -$23,812.00
Net Income Ratio 0 0 0 0
EPS 0.0718 -0.0039 -0.0004 -0.003
EPS Diluted 0.0718 -0.0039 -0.0004 -0.003
Weighted Average Shares Out $5.62 M $9.06 M $7.93 M $7.89 M
Weighted Average Shares Out Diluted $5.62 M $9.06 M $7.93 M $7.89 M
Link